Champions Oncology, Inc. (CSBR) is a publicly traded Healthcare sector company. As of May 21, 2026, CSBR trades at $5.99 with a market cap of $84.29M and a P/E ratio of 17.65. CSBR moved +0.00% today. Year to date, CSBR is -9.16%; over the trailing twelve months it is +2.20%. Its 52-week range spans $3.75 to $11.99. Rallies surfaces CSBR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded CSBR stock?
Rallies tracks politician and congressional stock disclosures for CSBR, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Mendelson Daniel Newman bought 1.00K (~$6.50K) on Jan 12, 2024.
Mendelson Daniel Newman bought 2.00K (~$12.54K) on Jan 11, 2024.
Mendelson Daniel Newman bought 2.94K (~$18.58K) on Jan 10, 2024.
CSBR Analyst Consensus
CSBR analyst coverage data. Average price target: $0.00.
Common questions about CSBR
Which politicians traded CSBR stock?
Rallies tracks politician and congressional stock disclosures for CSBR, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in CSBR?
Yes. Rallies tracks politician and congressional stock disclosures for CSBR, including reported purchases, sales, dates, owners, and trade amounts when available.
Is CSBR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CSBR. It does not provide personalized investment advice.
